The Beat AML Master Trial found high remission rates and promising safety with triplet therapy in patients with acute myeloid leukemia (AML), according to Ashley Yocum, PhD.

Among patients with pulmonary arterial hypertension, once-daily treprostinil palmitil inhalation powder for 16 weeks reduced ...

STS101 nasal powder, DHE, delivers fast, lasting relief from cardinal migraine symptoms, including photophobia, phonophobia, ...